Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sound Pharmaceuticals Inc.
DescriptionLocally injected short interfering RNA (siRNA) against cyclin dependent kinase inhibitor 1B (CDKN1B)
Molecular Target Cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationHearing loss
Indication DetailsTreat deafness and to induce regeneration of cochlear cells
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today